Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
The Lancet. Oncology.
Times cited: 11
The abscopal effect associated with a systemic anti-melanoma immune response.
International journal of radiation oncology, biology, physics.
Times cited: 119